Maternal Cardiovascular and Metabolic Modifications Secondary to the Use of Betamethasone for Fetal Lung Maturation

Authors

  • Keibis Jiménez Central Hospital Dr. “Urquinaona”
  • Eduardo Reyna Hospital Central Dr. “Urquinaona”
  • Mery Guerra Hospital Central Dr. “Urquinaona”
  • Yolima Ruiz Central Hospital Dr. “Urquinaona”
  • Duly Torres Central Hospital Dr. “Urquinaona”
  • Joel Santos Central Hospital Dr. “Urquinaona”
  • Jhoan Aragón Central Hospital Dr. “Urquinaona”
  • Jorly Mejia Central Hospital Dr. “Urquinaona”
  • Nadia Reyna Central Hospital Dr. “Urquinaona”

Abstract

The purpose of the research is to determine the maternal cardiovascular and metabolic modifications secondary to the use of betamethasones for fetal lung maturation. The research is explanatory, prospective and longitudinal, with a quasi-experimental design and an intentional non-probabilistic sample of 30 patients who attended the high-risk prenatal consultation at the “Dr. “Urquinaona.”

Downloads

Download data is not yet available.

Downloads

Published

2024-05-20

How to Cite

Jiménez, K., Reyna, E., Guerra, M., Ruiz, Y., Torres, D., Santos, J., Aragón, J., Mejia, J., & Reyna, N. (2024). Maternal Cardiovascular and Metabolic Modifications Secondary to the Use of Betamethasone for Fetal Lung Maturation. Observador Del Conocimiento, 2(4), 131–140. Retrieved from https://revistaoc.oncti.gob.ve/index.php/odc/article/view/527

Issue

Vol. 2 No. 4 (2014): abril

Section

Artículos

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

Most read articles by the same author(s)